Detection and Quantification of the Relationship between the Ratio of Triglycerides over High-Density Lipoprotein Cholesterol and the Level of Serum Uric Acid: One Cross-Sectional Study

Table 5

Magnitude of the effect for TG/HDL-C on the level of uric acid in both the established and exploration subgroups.

	N	Effect size (95% CI)	(interaction)
Sex (n)			0.1369
Male	2913	13.80 (0.50, 27.10)
Female	2489	19.07 (3.28, 34.87)
Age (years)			0.9084
≤50	3637	12.67 (−0.60, 25.95)
>50	1765	12.31 (−1.68, 26.30)
BMI (Kg/m^2)			0.1288
≤18.5	261	−4.28 (−37.86, 29.30)
18.5<BMI≤24	3005	5.99 (−8.91, 20.90)
>24	2136	12.13 (−1.12, 25.39)
SBP (mmHg)			0.7805
≤120	3160	13.04 (−0.69, 26.77)
>120	2242	12.20 (−1.15, 25.56)
DBP (mmHg)			0.6619
≤80	4145	11.77 (−1.78, 25.32)
>80	1257	13.24 (−0.40, 26.89)
Smoking status			0.3991
Nonsmokers	3979	15.59 (1.66, 29.52)
Occasional smokers	340	11.52 (−4.93, 27.98)
Smokers	1083	10.97 (−2.64, 24.58)
Drinking status			0.7667
Nondrinkers	2957	14.00 (0.14, 27.87)
Occasional drinkers	1532	12.17 (−1.43, 25.78)
Drinkers	913	11.43 (−2.89, 25.75)
Exercise status			0.2347
Low-intensity group	3999	12.82 (−0.43, 26.07)
Medium-intensity group	812	14.54 (−0.34, 29.42)
High-intensity group	591	5.50 (−10.13, 21.13)

Adjustment variables: monocytes, lymphocytes, RBC, WBC, platelets, height, weight, waist, TG, HDL-C, LDL-C, TC, fasting glucose, ALT, and AST. .